Evidence map›Paper›PMID 26176306›Full record

ReviewHuman vaccines & immunotherapeutics2016

Prevention of pneumococcal infections during mass gathering.

Jaffar A Al-Tawfiq, Ziad A Memish

Open access · bronzeAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Article
  6. The Hajj 2019 Vaccine Requirements and Possible New Challenges.Journal of epidemiology and global health · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Proportion of adult community-acquired pneumonia cases attributable to Streptococcus pneumoniae among Hajj pilgrims in 2016.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2018
    Article
  11. Review
  12. Article
  13. Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2016
    Article
  14. The annual Hajj pilgrimage-minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2016
    Article
  15. Vaccination in Hajj: An Overview of the Recent Findings.International journal of preventive medicine · 2016
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Jaffar A Al-Tawfiqa Johns Hopkins Aramco Healthcare ; Dhahran , Kingdom of Saudi Arabia.
Ziad A Memishc Ministry of Health and College of Medicine; Alfaisal University ; Riyadh , Saudi Arabia.
Alfaisal University · SAIndianapolis Zoo · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interest in mass gathering and its implications has been increasing due to globalization and international travel. The potential occurrence of infectious disease outbreaks during mass gathering is most feared. In this context, respiratory tract infections are of great concern due to crowding in a limited space which facilitates and magnifies the potential of disease spread among attendees. Pneumococcal disease is best described among pilgrims to Makkah and vaccination is one of the methods for the prevention of this disease. Pneumonia was described in a mass gathering with a prevalence of 4.8/100,000 pilgrims and contributes to 15-39% of hospitalizations. Various studies showed that 7-37% of pilgrims are 65 y of age or older. The uptake of pneumococcal vaccine among pilgrims is low at 5%. There is no available data to make strong recommendations for S. pneumoniae vaccination of all pilgrims, it is important that a high risk population receive the indicated vaccination. We reviewed the available literature on the burden of pneumococcal infections during mass gathering and evaluate the available literature on pneumococcal vaccinations for attendees of mass gathering.

Indexed as

CrowdingVaccinationHumansIslamPneumococcal InfectionsPneumococcal VaccinesRespiratory Tract InfectionsStreptococcus pneumoniaeTravelPneumococcal VaccinesMass gathering, Streptococcus pneumoniae, pneumococcus, Hajj, pilgrimage

Identifiers

PMID26176306
PMCPMC5049738
OpenAlexW1868333800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.